Hikma Pharmaceuticals PLC (LON:HIK)
London · Delayed Price · Currency is GBP · Price in GBX 1,636.00
+12.00 (0.74%)
Aug 21, 2026, 4:35 PM GMT
Hikma Pharmaceuticals Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3,419 | 3,349 | 3,127 | 2,875 | 2,517 | 2,553 |
Revenue Growth | 2.09% | 7.10% | 8.77% | 14.22% | -1.41% | 9.06% |
Gross Profit Gross Profit Growth | 1,506 | 1,457 | 1,419 | 1,407 | 1,265 | 1,301 |
Operating Income Operating Income Growth | 680 | 648 | 614 | 625 | 498 | 561 |
Net Income Net Income Growth | 387 | 402 | 359 | 190 | 188 | 421 |
Earnings Per Share EPS Growth | 1.76 | 1.81 | 1.61 | 0.85 | 0.84 | 1.81 |
EPS Growth | -2.89% | 12.42% | 89.41% | 1.19% | -53.51% | -0.22% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Injectables Injectables Growth | 1,425 | 1,423 | 1,306 | 1,203 | 1,140 | 1,053 |
Hikma Rx Hikma Rx Growth | 1,035 | 1,037 | 1,026 | 937 | 672 | 820 |
Branded Branded Growth | 914 | 849 | 769 | 714 | 691 | 669 |
Others Others Growth | 46 | 40 | 26 | 21 | 14 | 11 |
Total Total Growth | 3,420 | 3,349 | 3,127 | 2,875 | 2,517 | 2,553 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 289 | 243 | 213 | 229 | 292 | 450 |
Total Debt Total Debt Growth | 1,957 | 1,604 | 1,306 | 1,191 | 1,283 | 846 |
Net Cash (Debt) Net Cash Growth | -1,668 | -1,361 | -1,093 | -962 | -991 | -396 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -7.55 | -6.11 | -4.89 | -4.33 | -4.41 | -1.70 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 489 | 436 | 564 | 608 | 530 | 638 |
Capital Expenditures CapEx Growth | -251 | -197 | -165 | -169 | -138 | -145 |
Free Cash Flow Free Cash Flow Growth | 238 | 239 | 399 | 439 | 392 | 493 |
Free Cash Flow Growth | -0.42% | -40.10% | -9.11% | 11.99% | -20.49% | 68.84% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 44.05% | 43.51% | 45.38% | 48.94% | 50.26% | 50.96% |
Operating Margin | 19.89% | 19.35% | 19.63% | 21.74% | 19.79% | 21.97% |
Pretax Margin | 14.95% | 15.50% | 14.55% | 9.77% | 9.26% | 21.31% |
Profit Margin | 11.32% | 12.00% | 11.48% | 6.61% | 7.47% | 16.49% |
FCF Margin | 6.96% | 7.14% | 12.76% | 15.27% | 15.57% | 19.31% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.616 | 0.840 | 0.800 | 0.720 | 0.560 | 0.540 |
Dividend Per Share Growth | 0.96% | 5.00% | 11.11% | 28.57% | 3.70% | 8.00% |
Dividend Yield | 3.78% | 4.21% | 3.47% | 3.52% | 3.43% | 2.11% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 12.35 | 11.49 | 15.41 | 26.52 | 21.91 | 16.52 |
Forward PE | 9.35 | 8.95 | 10.90 | 10.80 | 9.65 | 14.20 |
P/FCF Ratio | 19.19 | 19.33 | 13.87 | 11.48 | 10.51 | 14.11 |
PS Ratio | 1.34 | 1.38 | 1.77 | 1.75 | 1.64 | 2.72 |